{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:37:56Z","timestamp":1788950276422,"version":"build-2803163510"},"reference-count":243,"publisher":"FapUNIFESP (SciELO)","issue":"3","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. bras. pneumol."],"abstract":"<jats:p>ABSTRACT Cystic fibrosis (CF) is an autosomal recessive genetic disorder characterized by dysfunction of the CFTR gene. It is a multisystem disease that most often affects White individuals. In recent decades, various advances in the diagnosis and treatment of CF have drastically changed the scenario, resulting in a significant increase in survival and quality of life. In Brazil, the current neonatal screening program for CF has broad coverage, and most of the Brazilian states have referral centers for the follow-up of individuals with the disease. Previously, CF was limited to the pediatric age group. However, an increase in the number of adult CF patients has been observed, because of the greater number of individuals being diagnosed with atypical forms (with milder phenotypic expression) and because of the increase in life expectancy provided by the new treatments. However, there is still great heterogeneity among the different regions of Brazil in terms of the access of CF patients to diagnostic and therapeutic methods. The objective of these guidelines was to aggregate the main scientific evidence to guide the management of these patients. A group of 18 CF specialists devised 82 relevant clinical questions, divided into five categories: characteristics of a referral center; diagnosis; treatment of respiratory disease; gastrointestinal and nutritional treatment; and other aspects. Various professionals working in the area of CF in Brazil were invited to answer the questions devised by the coordinators. We used the PubMed database to search the available literature based on keywords, in order to find the best answers to these questions.<\/jats:p>","DOI":"10.1590\/s1806-37562017000000065","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T14:15:04Z","timestamp":1500473704000},"page":"219-245","source":"Crossref","is-referenced-by-count":93,"title":["Brazilian guidelines for the diagnosis and treatment of cystic fibrosis"],"prefix":"10.1590","volume":"43","author":[{"given":"Rodrigo Abensur","family":"Athanazio","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Vicente Ribeiro Ferreira da","family":"Silva Filho","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil; Hospital Albert Einstein,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto Andrade","family":"Vergara","sequence":"additional","affiliation":[{"name":"Rede Funda\u00e7\u00e3o Hospitalar do Estado de Minas Gerais,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio Fernando","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Ant\u00f4nio","family":"Riedi","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elenara da Fonseca Andrade","family":"Procianoy","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fab\u00edola Villac","family":"Adde","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Jos\u00e9 Caldeira","family":"Reis","sequence":"additional","affiliation":[{"name":"Rede Funda\u00e7\u00e3o Hospitalar do Estado de Minas Gerais,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Dirceu","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00eddia Alice","family":"Torres","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Bicalho de","family":"Fuccio","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Hospitalar do Estado de Minas Gerais,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias","family":"Epifanio","sequence":"additional","affiliation":[{"name":"Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f4nica de C\u00e1ssia","family":"Firmida","sequence":"additional","affiliation":[{"name":"Universidade do Estado do Rio de Janeiro,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neiva","family":"Damaceno","sequence":"additional","affiliation":[{"name":"Irmandade da Santa Casa de Miseric\u00f3rdia de S\u00e3o Paulo,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto","family":"Ludwig-Neto","sequence":"additional","affiliation":[{"name":"Hospital Infantil Joana de Gusm\u00e3o,  Brasil; Secretaria Estadual de Sa\u00fade de Santa Catarina,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Jos\u00e9 Cauduro","family":"Mar\u00f3stica","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre,  Brasil; Universidade Federal do Rio Grande do Sul,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia Zahi","family":"Rached","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana Fonseca de Oliveira","family":"Melo","sequence":"additional","affiliation":[{"name":"Rede Funda\u00e7\u00e3o Hospitalar do Estado de Minas Gerais,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Ara\u00fajo","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Freitas Velloso","family":"Monte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurinda Yoko Shinzato","family":"Higa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania Wrobel","family":"Folescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Augusto de Lima","family":"Marson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Sad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria de F\u00e1tima Correa Pimenta","family":"Servidoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo","family":"Kussek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salmo","family":"Raskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Della","family":"Zuana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albin","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneliese","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Barbisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Hochhegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Emilio","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine Sarmento da","family":"Veiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ricachinevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dante","family":"Escuissato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Brandemburgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanirso de","family":"Aquino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto Bueno","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim Carlos","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Muramato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lusmaia Damasceno Camargo","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio","family":"Donadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos C\u00e9sar Santos de","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Angela","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ang\u00e9lica","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariane","family":"Canan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Buarque de","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murilo","family":"Britto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Roth Tarso","family":"Dalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina Terse Trindade","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9ria de Carvalho","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Lacerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabet Vilar","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Hessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocemara","family":"Gurmini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenycia","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Coelho","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f4nica Chang","family":"Wayhs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam Isabel Santos","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene Gon\u00e7alves dos Santos","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia de Castro de","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano T\u00falio Maciel","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna L\u00facia","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Antonio de Abreu e","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo de Tarso","family":"Dalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Maria de","family":"Noronha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Helena","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer Marcantonio","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Rozov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ticiana da Costa","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2017,6]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jcf.2007.03.006","article-title":"Incidence of cystic fibrosis in five different states of Brazil as determined by screening of p F508del, mutation at the CFTR gene in newborns and patients","volume":"7","author":"Raskin S","year":"2008","journal-title":"J Cyst Fibros"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1164\/rccm.201504-0656UP","article-title":"Update in Cystic Fibrosis 2014","volume":"192","author":"Ong T","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMra1300109","article-title":"Origins of cystic fibrosis lung disease","volume":"372","author":"Stoltz DA","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/00063198-200311000-00009","article-title":"Nonclassic cystic fibrosis and CFTR-related diseases","volume":"9","author":"Boyle MP","year":"2003","journal-title":"Curr Opin Pulm Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jcf.2014.03.009","article-title":"European Cystic Fibrosis Society Standards of Care Framework for the Cystic Fibrosis Centre","volume":"13","author":"Conway S","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"7147","key":"ref6","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/bmj.316.7147.1771","article-title":"Clinical outcome in relation to care in centres specialising in cystic fibrosis cross sectional study","volume":"316","author":"Mahadeva R","year":"1998","journal-title":"BMJ"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1378\/chest.123.1.20","article-title":"Factors influencing outcomes in cystic fibrosis a center-based analysis","volume":"123","author":"Johnson C","year":"2003","journal-title":"Chest"},{"key":"ref8","series-title":"Cystic fibrosis standards of care Australia","author":"Bell SC","year":"2008"},{"key":"ref9","series-title":"Standards for the Clinical Care of Children and Adults with cystic fibrosis in the UK","year":"2011","edition":"Second"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1183\/13993003.00592-2015","article-title":"Report of the European Respiratory Society\/European Cystic Fibrosis Society task force on the care of adults with cystic fibrosis","volume":"47","author":"Elborn JS","year":"2016","journal-title":"Eur Respir J"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ccm.2015.11.007","article-title":"Cystic Fibrosis Transitions of Care Lessons Learned and Future Directions for Cystic Fibrosis","volume":"37","author":"Okumura MJ","year":"2016","journal-title":"Clin Chest Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"i64","DOI":"10.1136\/bmjqs-2013-002364","article-title":"Improving transition from paediatric to adult cystic fibrosis care programme implementation and evaluation","volume":"23","author":"Okumura MJ","year":"2014","journal-title":"BMJ Qual Saf"},{"issue":"5","key":"ref13","first-page":"459","article-title":"Clinical changes of patients with cystic fibrosis during transition from pediatric to adult care ?J Adolesc","volume":"43","author":"Dugu\u00e9p\u00e9roux I","year":"2008","journal-title":"Health"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1542\/peds.113.3.e197","article-title":"Prevalence and correlates of successful transfer from pediatric to adult health care among a cohort of young adults with complex congenital heart defects","volume":"113","author":"Reid GJ","year":"2004","journal-title":"Pediatrics"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ppul.22647","article-title":"Evaluation of a cystic fibrosis transition program from pediatric to adult care","volume":"48","author":"Chaudhry SR","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"ref16","series-title":"Rede de Aten\u00e7\u00e3o \u00e0 Sa\u00fade para Pessoas com Fibrose C\u00edstica--Padroniza\u00e7\u00e3o dos Cuidados na Fibrose C\u00edstica. Condi\u00e7\u00f5es de oferta dos centros de refer\u00eancia, cuidados compartilhados, cuidados de transi\u00e7\u00e3o e interna\u00e7\u00e3o","first-page":"[1 p.]","author":"Machado CD","year":"2017"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/676882","article-title":"Infection prevention and control guideline for cystic fibrosis 2013 update","volume":"35","author":"Saiman L","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1378\/chest.13-2404","article-title":"Point does the risk of cross infection warrant exclusion of adults with cystic fibrosis from cystic fibrosis foundation events? Yes","volume":"145","author":"Jain M","year":"2014","journal-title":"Chest"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1258\/jrsm.2008.s18007","article-title":"Segregation is good for patients with cystic fibrosis","volume":"101","author":"Conway S","year":"2008","journal-title":"J R Soc Med"},{"issue":"2","key":"ref20","first-page":"63","article-title":"The evolution of blood-spot newborn screening","volume":"3","author":"Bhattacharya K","year":"2014","journal-title":"Transl Pediatr"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2008.05.005","article-title":"Guidelines for diagnosis of cystic fibrosis in newborns through older adults Cystic Fibrosis Foundation consensus report","volume":"153","author":"Farrell PM","year":"2008","journal-title":"J Pediatr"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2223\/JPED.1345","article-title":"Neonatal cystic fibrosis screening program in the state of Paran\u00e1 evaluation 30 months after implementation [Article in Portuguese].","volume":"81","author":"Santos GP","year":"2005","journal-title":"J Pediatr (Rio J)"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jcf.2014.03.010","article-title":"European Cystic Fibrosis Society Standards of Care Best Practice guidelines","volume":"13","author":"Smyth AR","year":"2014","journal-title":"J Cyst Fibros"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2016.09.064","article-title":"Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation","volume":"181S","author":"Farrell PM","year":"2017","journal-title":"J Pediatr"},{"key":"ref25","series-title":"Guidelines for the Performance of the Sweat Test for the Investigation of Cystic Fibrosis in the UK, 2nd version","first-page":"[1 p.]","author":"Heap S","year":"2014"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jpeds.2007.03.002","article-title":"Diagnostic sweat testing the Cystic Fibrosis Foundation guidelines","volume":"151","author":"LeGrys VA","year":"2007","journal-title":"J Pediatr"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1569-1993(02)00146-7","article-title":"Sweat conductivity and chloride titration for cystic fibrosis diagnosis in 3834 subjects","volume":"2","author":"Lezana JL","year":"2003","journal-title":"J Cyst Fibros"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jcf.2014.01.002","article-title":"Sweat conductivity an accurate diagnostic test for cystic fibrosis?","volume":"13","author":"Mattar AC","year":"2014","journal-title":"J Cyst Fibros"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13073-015-0223-6","article-title":"Targeted therapies to improve CFTR function in cystic fibrosis","volume":"7","author":"Brodlie M","year":"2015","journal-title":"Genome Med"},{"issue":"7","key":"ref30","first-page":"500","article-title":"CFTR Modulators for the Treatment of Cystic Fibrosis","volume":"39","author":"Pettit RS","year":"2014","journal-title":"P T"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/ejhg.2008.136","article-title":"Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders--updated European recommendations","volume":"17","author":"Dequeker E","year":"2009","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jcf.2008.03.009","article-title":"Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice","volume":"7","author":"Castellani C","year":"2008","journal-title":"J Cyst Fibros"},{"issue":"7","key":"ref33","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/thx.2005.043539","article-title":"Cystic fibrosis terminology and diagnostic algorithms","volume":"61","author":"De Boeck K","year":"2006","journal-title":"Thorax"},{"issue":"12","key":"ref34","doi-asserted-by":"crossref","first-page":"a009480","DOI":"10.1101\/cshperspect.a009480","article-title":"Assessing the Disease-Liability of Mutations in CFTR","volume":"2","author":"Ferec C","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"12","key":"ref35","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/GIM.0b013e31818e55a2","article-title":"Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders","volume":"10","author":"Moskowitz SM","year":"2008","journal-title":"Genet Med"},{"issue":"4","key":"ref36","first-page":"363","article-title":"CFTR functional measurements in human models for diagnosis, prognosis and personalized therapy Report on the pre-conference meeting to the 11th ECFS Basic Science Conference, Malta, 26-29 March 2014","volume":"13","author":"Beekman JM","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1183\/09031936.00057512","article-title":"CFTR biomarkers time for promotion to surrogate end-point","volume":"41","author":"De Boeck K","year":"2013","journal-title":"Eur Respir J"},{"issue":"8","key":"ref38","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1128\/JCM.00764-14","article-title":"Time between collection and storage significantly influences bacterial sequence composition in sputum samples from cystic fibrosis respiratory infections","volume":"52","author":"Cuthbertson L","year":"2014","journal-title":"J Clin Microbiol"},{"key":"ref39","series-title":"Laboratory Standards for Processing Microbiological Samples from People with Cystic Fibrosis","year":"2010","edition":"1st"},{"issue":"4","key":"ref40","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-1784","article-title":"Clinical Practice Guidelines From the Cystic Fibrosis Foundation for Preschoolers With Cystic Fibrosis","volume":"137","author":"Lahiri T","year":"2016","journal-title":"Pediatrics"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.clinmicnews.2012.02.001","article-title":"Practical Laboratory Aspects of Cystic Fibrosis Microbiology an Update, Part II","volume":"34","author":"Kiska DL","year":"2012","journal-title":"Clin Microbiol Newsl"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cll.2014.02.001","article-title":"Infections in patients with cystic fibrosis diagnostic microbiology update","volume":"34","author":"Gilligan PH","year":"2014","journal-title":"Clin Lab Med"},{"key":"ref43","series-title":"Cystic fibrosis microbiology. Cumitech 43. Washington,","author":"Gilligan PH","year":"2006"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcf.2013.09.004","article-title":"Culture-based diagnostic microbiology in cystic fibrosis can we simplify the complexity?","volume":"13","author":"Burns JL","year":"2014","journal-title":"J Cyst Fibros"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12866-014-0335-y","article-title":"Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain towards standard of care practices","volume":"14","author":"Caballero Jde D","year":"2014","journal-title":"BMC Microbiol"},{"issue":"6","key":"ref46","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1128\/JCM.00330-12","article-title":"Evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of nonfermenting gram-negative bacilli isolated from cultures from cystic fibrosis patients","volume":"50","author":"Marko DC","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1513\/AnnalsATS.201408-393OC","article-title":"A systematic review of factors associated with health-related quality of life in adolescents and adults with cystic fibrosis","volume":"12","author":"Habib AR","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1513\/AnnalsATS.201301-017ST","article-title":"An official American Thoracic Society workshop report optimal lung function tests for monitoring cystic fibrosis, bronchopulmonary dysplasia, and recurrent wheezing in children less than 6 years of age","volume":"10","author":"Rosenfeld M","year":"2013","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1513\/AnnalsATS.201501-021FR","article-title":"Multiple-Breath Washout as a Lung Function Test in Cystic Fibrosis A Cystic Fibrosis Foundation Workshop Report","volume":"12","author":"Subbarao P","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"12","key":"ref50","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/ppul.23314","article-title":"Lung function comparison between two decades in cystic fibrosis children A single centre study","volume":"50","author":"Tridello G","year":"2015","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"ref51","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1513\/pats.200611-179HT","article-title":"Chest radiographs for outcome assessment in cystic fibrosis","volume":"4","author":"Cleveland RH","year":"2007","journal-title":"Proc Am Thorac Soc"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/thx.2005.045146","article-title":"Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis","volume":"61","author":"de Jong PA","year":"2006","journal-title":"Thorax"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1148\/radiol.14132201","article-title":"Pulmonary disease in cystic fibrosis assessment with chest CT at chest radiography dose levels","volume":"273","author":"Ernst CW","year":"2014","journal-title":"Radiology"},{"issue":"7","key":"ref54","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1164\/rccm.201105-0816OC","article-title":"Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis","volume":"184","author":"Sanders DB","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1148\/radiology.195.3.7753989","article-title":"Bronchiectasis comparison of preoperative thin-section CT and pathologic findings in resected specimens","volume":"195","author":"Kang EY","year":"1995","journal-title":"Radiology"},{"issue":"4","key":"ref56","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/thoraxjnl-2013-204176","article-title":"Is chest CT useful in newborn screened infants with cystic fibrosis at 1 year of age","volume":"69","author":"Thia LP","year":"2014","journal-title":"Thorax"},{"issue":"2","key":"ref57","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcf.2013.09.003","article-title":"HRCT and MRI of the lung in children with cystic fibrosis comparison of different scoring systems","volume":"13","author":"Sileo C","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1513\/AnnalsATS.201407-338OC","article-title":"Chest computed tomography predicts the frequency of pulmonary exacerbations in children with cystic fibrosis","volume":"12","author":"Sanders DB","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"ref59","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/ppul.21107","article-title":"Cystic fibrosis HRCT scores correlate strongly with Pseudomonas infection","volume":"44","author":"Robinson TE","year":"2009","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"ref60","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1183\/20734735.021014","article-title":"Inhaled therapy in cystic fibrosis agents, devices and regimens","volume":"11","author":"Agent P","year":"2015","journal-title":"Breathe (Sheff)"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1258\/jrsm.2009.s19003","article-title":"Nebulizer therapy in cystic fibrosis an overview","volume":"102","author":"Collins N","year":"2009","journal-title":"J R Soc Med"},{"key":"ref62","series-title":"Nebuliser therapy in cystic fibrosis","year":"2013"},{"issue":"S9","key":"ref63","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1002\/ppul.20860","article-title":"The science of aerosol delivery in cystic fibrosis","volume":"43","author":"Geller DE","year":"2008","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"ref64","first-page":"CD007639","article-title":"Nebuliser systems for drug delivery in cystic fibrosis","author":"Daniels T","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"ref65","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1183\/09031936.00166410","article-title":"What the pulmonary specialist should know about the new inhalation therapies","volume":"37","author":"Laube BL","year":"2011","journal-title":"Eur Respir J"},{"issue":"2","key":"ref66","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1590\/S1806-37132014000200004","article-title":"Effect that an educational program for cystic fibrosis patients and caregivers has on the contamination of home nebulizers","volume":"40","author":"Della Zuana A","year":"2014","journal-title":"J Bras Pneumol"},{"issue":"5","key":"ref67","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jcf.2012.11.013","article-title":"Baby bottle steam sterilizers disinfect home nebulizers inoculated with bacterial respiratory pathogens","volume":"12","author":"Towle D","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"4","key":"ref68","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jhin.2009.05.011","article-title":"Impact of hypochlorite-based disinfection on bacterial contamination of cystic fibrosis patients' home-nebulisers","volume":"72","author":"Reychler G","year":"2009","journal-title":"J Hosp Infect"},{"issue":"2","key":"ref69","first-page":"131","article-title":"Safety and cleaning of medical materials and devices ?J Biomed Mater","volume":"53","author":"Merritt K","year":"2000","journal-title":"Res"},{"issue":"12","key":"ref70","first-page":"CD001401","article-title":"Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis","author":"Warnock L","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"ref71","first-page":"CD003147","article-title":"Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis","author":"McIlwaine M","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"ref72","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/thoraxjnl-2012-202915","article-title":"Long-term multicentre randomised controlled study of high frequency chest wall oscillation versus positive expiratory pressure mask in cystic fibrosis","volume":"68","author":"McIlwaine MP","year":"2013","journal-title":"Thorax"},{"issue":"4","key":"ref73","first-page":"CD002769","article-title":"Non-invasive ventilation for cystic fibrosis","author":"Moran F","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"ref74","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/thx.2007.082602","article-title":"Randomised placebo controlled trial of non-invasive ventilation for hypercapnia in cystic fibrosis","volume":"63","author":"Young AC","year":"2008","journal-title":"Thorax"},{"issue":"10","key":"ref75","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/thorax.58.10.880","article-title":"Non-invasive ventilation assists chest physiotherapy in adults with acute exacerbations of cystic fibrosis","volume":"58","author":"Holland AE","year":"2003","journal-title":"Thorax"},{"issue":"6","key":"ref76","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4187\/002013209790983205","article-title":"Airway-clearance therapy guidelines and implementation","volume":"54","author":"Lester MK","year":"2009","journal-title":"Respir Care"},{"issue":"6","key":"ref77","first-page":"CD002768","article-title":"Physical exercise training for cystic fibrosis","author":"Radtke T","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"ref78","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1378\/chest.126.4.1204","article-title":"Strength vs aerobic training in children with cystic fibrosis a randomized controlled trial","volume":"126","author":"Orenstein DM","year":"2004","journal-title":"Chest"},{"issue":"3","key":"ref79","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ppul.10015","article-title":"Randomized controlled study of in-hospital exercise training programs in children with cystic fibrosis","volume":"33","author":"Selvadurai HC","year":"2002","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"ref80","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/MCP.0b013e32834b6af4","article-title":"The role of exercise in maintaining health in cystic fibrosis","volume":"17","author":"Dwyer TJ","year":"2011","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"ref81","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jpeds.2014.12.001","article-title":"Physical exercise recommendations improve postural changes found in children and adolescents with cystic fibrosis a randomized controlled trial","volume":"166","author":"Schindel CS","year":"2015","journal-title":"J Pediatr"},{"issue":"8","key":"ref82","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.rmed.2014.04.022","article-title":"Exercise programme in patients with cystic fibrosis a randomized controlled trial","volume":"108","author":"Rovedder PM","year":"2014","journal-title":"Respir Med"},{"issue":"10","key":"ref83","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.200705-664OC","article-title":"Cystic fibrosis pulmonary guidelines chronic medications for maintenance of lung health","volume":"176","author":"Flume PA","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"ref84","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis The Pulmozyme Study Group","volume":"331","author":"Fuchs HJ","year":"1994","journal-title":"N Engl J Med"},{"issue":"3","key":"ref85","first-page":"CD001127","article-title":"Dornase alfa for cystic fibrosis","author":"Jones AP","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"ref86","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/ppul.21388","article-title":"Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in cystic fibrosis","volume":"46","author":"Konstan MW","year":"2011","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"ref87","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.201207-1160OE","article-title":"Cystic fibrosis pulmonary guidelines Chronic medications for maintenance of lung health","volume":"187","author":"Mogayzel Jr PJ","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"ref88","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1067\/mpd.2001.118570","article-title":"A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities","volume":"139","author":"Quan JM","year":"2001","journal-title":"J Pediatr"},{"issue":"9","key":"ref89","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/ppul.21267","article-title":"Dornase alfa improves the health-related quality of life among Brazilian patients with cystic fibrosis--a one-year prospective study","volume":"45","author":"Rozov T","year":"2010","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"ref90","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1378\/chest.110.4.889","article-title":"Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease Pulmozyme Study Group","volume":"110","author":"McCoy K","year":"1996","journal-title":"Chest"},{"issue":"10","key":"ref91","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/thorax.57.10.841","article-title":"Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis","volume":"57","author":"Suri R","year":"2002","journal-title":"Thorax"},{"issue":"9290","key":"ref92","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0140-6736(01)06412-1","article-title":"Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis a randomised trial","volume":"358","author":"Suri R","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"ref93","doi-asserted-by":"crossref","first-page":"e549","DOI":"10.1542\/peds.2005-0308","article-title":"A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis","volume":"116","author":"Fitzgerald DA","year":"2005","journal-title":"Pediatrics"},{"key":"ref94","first-page":"CD001127","article-title":"Dornase alfa for cystic fibrosis","volume":"4","author":"Yang C","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"ref95","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1569-1993(03)00090-0","article-title":"DNase in stable cystic fibrosis infants a pilot study","volume":"2","author":"Berge MT","year":"2003","journal-title":"J Cyst Fibros"},{"issue":"5","key":"ref96","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ppul.1061","article-title":"Use of computerized tomography and chest x-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years a preliminary study","volume":"31","author":"Nasr SZ","year":"2001","journal-title":"Pediatr Pulmonol"},{"issue":"10","key":"ref97","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/ppul.20685","article-title":"Dornase alfa is well tolerated data from the epidemiologic registry of cystic fibrosis","volume":"42","author":"McKenzie SG","year":"2007","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"ref98","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa043900","article-title":"A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis","volume":"354","author":"Elkins MR","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"ref99","first-page":"CD001506","article-title":"Nebulised hypertonic saline for cystic fibrosis","author":"Wark PA","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"ref100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/thoraxjnl-2014-206716","article-title":"A randomised trial of hypertonic saline during hospitalisation for exacerbation of cystic fibrosis","volume":"71","author":"Dentice RL","year":"2016","journal-title":"Thorax"},{"issue":"6","key":"ref101","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1164\/rccm.201109-1666OC","article-title":"Long-term inhaled dry powder mannitol in cystic fibrosis an international randomized study","volume":"185","author":"Aitken ML","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"ref102","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1183\/09031936.00187510","article-title":"Inhaled dry powder mannitol in cystic fibrosis an efficacy and safety study","volume":"38","author":"Bilton D","year":"2011","journal-title":"Eur Respir J"},{"issue":"4","key":"ref103","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jcf.2012.11.002","article-title":"Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosis","volume":"12","author":"Bilton D","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"11","key":"ref104","first-page":"CD004197","article-title":"Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis","author":"Langton Hewer SC","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"ref105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcf.2012.06.001","article-title":"Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis","volume":"12","author":"Proesmans M","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"4","key":"ref106","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/thx.2009.121657","article-title":"Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis the ELITE trial","volume":"65","author":"Ratjen F","year":"2010","journal-title":"Thorax"},{"issue":"9","key":"ref107","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archpediatrics.2011.136","article-title":"Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis","volume":"165","author":"Treggiari MM","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"ref108","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.syapm.2010.10.002","article-title":"Classification and identification of the Burkholderia cepacia complex Past, present and future","volume":"34","author":"Vandamme P","year":"2011","journal-title":"Syst Appl Microbiol"},{"issue":"12","key":"ref109","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1007\/s00253-016-7520-x","article-title":"Burkholderia an update on taxonomy and biotechnological potential as antibiotic producers","volume":"100","author":"Depoorter E","year":"2016","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"ref110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1513\/AnnalsATS.201408-395OC","article-title":"Burkholderia species infections in patients with cystic fibrosis in British Columbia, Canada 30 years' experience","volume":"12","author":"Zlosnik JE","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fcimb.2011.00018","article-title":"Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy","volume":"1","author":"Horsley A","year":"2011","journal-title":"Front Cell Infect Microbiol"},{"issue":"23","key":"ref112","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1001\/jama.2010.791","article-title":"Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis","volume":"303","author":"Dasenbrook EC","year":"2010","journal-title":"JAMA"},{"issue":"6","key":"ref113","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jcf.2013.04.009","article-title":"Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients An observational prospective cohort study of 11 patients","volume":"12","author":"Vanderhelst E","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"3","key":"ref114","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.rmed.2015.01.013","article-title":"Eradication of respiratory tract MRSA at a large adult cystic fibrosis centre","volume":"109","author":"Hall H","year":"2015","journal-title":"Respir Med"},{"issue":"1","key":"ref115","doi-asserted-by":"crossref","first-page":"00064","DOI":"10.1183\/23120541.00064-2015","article-title":"MRSA eradication of newly acquired lower respiratory tract infection in cystic fibrosis","volume":"2","author":"Valli\u00e8res E","year":"2016","journal-title":"ERJ Open Res"},{"issue":"3","key":"ref116","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jhin.2006.10.011","article-title":"Successful decolonization of methicillin-resistant Staphylococcus aureus in paediatric patients with cystic fibrosis (CF) using a three-step protocol","volume":"65","author":"Macfarlane M","year":"2007","journal-title":"J Hosp Infect"},{"issue":"3","key":"ref117","first-page":"CD001021","article-title":"Inhaled antibiotics for long-term therapy in cystic fibrosis","author":"Ryan G","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"ref118","series-title":"Antibiotic Treatment for Cystic Fibrosis","year":"2009","edition":"Third"},{"issue":"4","key":"ref119","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1590\/S1806-37132013000400015","article-title":"Pseudomonas aeruginosa infection in patients with cystic fibrosis scientific evidence regarding clinical impact, diagnosis, and treatment","volume":"39","author":"Silva Filho LV","year":"2013","journal-title":"J Bras Pneumol"},{"issue":"1","key":"ref120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","article-title":"Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients","volume":"2","author":"Lee TW","year":"2003","journal-title":"J Cyst Fibros"},{"issue":"24","key":"ref121","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJM199306173282403","article-title":"Efficacy of aerosolized tobramycin in patients with cystic fibrosis","volume":"328","author":"Ramsey BW","year":"1993","journal-title":"N Engl J Med"},{"issue":"1","key":"ref122","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with cystic fibrosis Cystic Fibrosis Inhaled Tobramycin Study Group","volume":"340","author":"Ramsey BW","year":"1999","journal-title":"N Engl J Med"},{"issue":"11","key":"ref123","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/ppul.21301","article-title":"An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis","volume":"45","author":"Oermann CM","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"ref124","series-title":"Clinical Guidelines: Care of Children with Cystic Fibrosis. Royal Brompton Hospital. 6th edition","author":"Balfour-Lynn IM","year":"2014"},{"issue":"1","key":"ref125","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcf.2010.10.003","article-title":"Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients The EAGER trial","volume":"10","author":"Konstan MW","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"5","key":"ref126","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jcf.2012.03.010","article-title":"A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis","volume":"11","author":"Littlewood KJ","year":"2012","journal-title":"J Cyst Fibros"},{"issue":"10","key":"ref127","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1513\/AnnalsATS.201404-166OC","article-title":"Cystic Fibrosis Foundation pulmonary guideline pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection","volume":"11","author":"Mogayzel Jr PJ","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"10","key":"ref128","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/thx.2005.057950","article-title":"Long term effects of azithromycin in patients with cystic fibrosis A double blind, placebo controlled trial","volume":"61","author":"Clement A","year":"2006","journal-title":"Thorax"},{"issue":"9338","key":"ref129","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(02)11081-6","article-title":"Long term azithromycin in children with cystic fibrosis a randomised, placebo-controlled crossover trial","volume":"360","author":"Equi A","year":"2002","journal-title":"Lancet"},{"issue":"6","key":"ref130","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.pupt.2009.03.002","article-title":"Effects of prolonged use of azithromycin in patients with cystic fibrosis A meta-analysis","volume":"22","author":"Florescu DF","year":"2009","journal-title":"Pulm Pharmacol Ther"},{"issue":"1","key":"ref131","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcf.2009.09.001","article-title":"Long-term daily high and low doses of azithromycin in children with cystic fibrosis a randomized controlled trial","volume":"9","author":"Kabra SK","year":"2010","journal-title":"J Cyst Fibros"},{"issue":"13","key":"ref132","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","article-title":"Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa a randomized controlled trial","volume":"290","author":"Saiman L","year":"2003","journal-title":"JAMA"},{"key":"ref133","first-page":"CD002203","article-title":"Macrolide antibiotics for cystic fibrosis","volume":"11","author":"Southern KW","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"17","key":"ref134","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.2010.563","article-title":"Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa a randomized controlled trial","volume":"303","author":"Saiman L","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"ref135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.inf.0000247109.44249.ac","article-title":"Maintenance azithromycin treatment in pediatric patients with cystic fibrosis long-term outcomes related to macrolide resistance and pulmonary function","volume":"26","author":"Tramper-Stranders GA","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"ref136","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ppul.22981","article-title":"How long should we maintain long-term azithromycin treatment in cystic fibrosis patients","volume":"50","author":"Willekens J","year":"2015","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"ref137","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1513\/AnnalsATS.201310-352OC","article-title":"Azithromycin may antagonize inhaled tobramycin when targeting Pseudomonas aeruginosa in cystic fibrosis","volume":"11","author":"Nick JA","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"9","key":"ref138","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines treatment of pulmonary exacerbations","volume":"180","author":"Flume PA","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"ref139","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2165\/00003088-198713040-00002","article-title":"Antibiotic pharmacokinetics in cystic fibrosis Differences and clinical significance","volume":"13","author":"de Groot R","year":"1987","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"ref140","first-page":"CD006682","article-title":"Duration of intravenous antibiotic therapy in people with cystic fibrosis","author":"Plummer A","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"ref141","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1164\/rccm.201001-0057OC","article-title":"Location and duration of treatment of cystic fibrosis respiratory exacerbations do not affect outcomes","volume":"182","author":"Collaco JM","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"ref142","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1465-9921-11-137","article-title":"Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations","volume":"11","author":"VanDevanter DR","year":"2010","journal-title":"Respir Res"},{"issue":"7","key":"ref143","first-page":"CD009730","article-title":"Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis","author":"Hurley MN","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"ref144","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1034\/j.1399-3003.2000.16d30.x","article-title":"Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis a European consensus","volume":"16","author":"D\u00f6ring G","year":"2000","journal-title":"Eur Respir J"},{"key":"ref145","first-page":"ii1","article-title":"BTS guidelines for home oxygen in children","volume":"64","author":"Balfour-Lynn IM","year":"2009","journal-title":"Thorax"},{"issue":"7","key":"ref146","first-page":"CD003884","article-title":"Oxygen therapy for cystic fibrosis","author":"Elphick HE","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"ref147","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1164\/rccm.201002-0157OC","article-title":"Cystic fibrosis pulmonary guidelines pulmonary complications: hemoptysis and pneumothorax","volume":"182","author":"Flume PA","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"ref148","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art Cystic Fibrosis Foundation Consensus Conference","volume":"37","author":"Stevens DA","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"11","key":"ref149","first-page":"CD002204","article-title":"Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis","author":"Elphick HE","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"ref150","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2217\/fmb.14.74","article-title":"Diagnosis of allergic bronchopulmonary aspergillosis a case-based approach","volume":"9","author":"Dhooria S","year":"2014","journal-title":"Future Microbiol"},{"issue":"8","key":"ref151","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cea.12141","article-title":"Allergic bronchopulmonary aspergillosis review of literature and proposal of new diagnostic and classification criteria","volume":"43","author":"Agarwal R","year":"2013","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"ref152","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/1753465812443094","article-title":"Management of allergic bronchopulmonary aspergillosis a review and update","volume":"6","author":"Mahdavinia M","year":"2012","journal-title":"Ther Adv Respir Dis"},{"issue":"4","key":"ref153","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jcf.2009.04.008","article-title":"Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis","volume":"8","author":"Cohen-Cymberknoh M","year":"2009","journal-title":"J Cyst Fibros"},{"issue":"1","key":"ref154","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.prrv.2012.11.004","article-title":"Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis","volume":"14","author":"Wong R","year":"2013","journal-title":"Paediatr Respir Rev"},{"issue":"5","key":"ref155","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1179\/1973947814Y.0000000194","article-title":"Role of nebulized amphotericin B in the management of allergic bronchopulmonary aspergillosis in cystic fibrosis Case report and review of literature","volume":"27","author":"Casciaro R","year":"2015","journal-title":"J Chemother"},{"issue":"4","key":"ref156","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036077","article-title":"Treatment of Aspergillus fumigatus in patients with cystic fibrosis a randomized, placebo-controlled pilot study","volume":"7","author":"Aaron SD","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"ref157","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1378\/chest.130.1.222","article-title":"Aspergillus bronchitis in cystic fibrosis","volume":"130","author":"Shoseyov D","year":"2006","journal-title":"Chest"},{"issue":"2","key":"ref158","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S2213-2600(12)70057-7","article-title":"A new era in the treatment of cystic fibrosis correction of the underlying CFTR defect","volume":"1","author":"Boyle MP","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"6","key":"ref159","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jcf.2014.09.005","article-title":"Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation","volume":"13","author":"De Boeck K","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"2","key":"ref160","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1164\/rccm.201404-0703OC","article-title":"Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis","volume":"190","author":"Rowe SM","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"ref161","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcf.2015.01.008","article-title":"Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation Safety and efficacy in an expanded access program in the United States","volume":"15","author":"Taylor-Cousar J","year":"2016","journal-title":"J Cyst Fibros"},{"issue":"11","key":"ref162","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1164\/rccm.201301-0153OC","article-title":"Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation","volume":"187","author":"Davies JC","year":"2013","journal-title":"Am J Resp Crit Care Med"},{"issue":"18","key":"ref163","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey BW","year":"2011","journal-title":"N Engl J Med"},{"issue":"21","key":"ref164","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0909825","article-title":"Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation","volume":"363","author":"Accurso FJ","year":"2010","journal-title":"N Engl J Med"},{"issue":"7","key":"ref165","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S2213-2600(14)70100-6","article-title":"Ataluren for the treatment of nonsense-mutation cystic fibrosis a randomised, double-blind, placebo-controlled phase 3 trial","volume":"2","author":"Kerem E","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"7","key":"ref166","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S2213-2600(14)70132-8","article-title":"A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation a phase 2 randomised controlled trial","volume":"2","author":"Boyle MP","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"2","key":"ref167","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccm.2007.02.002","article-title":"Inflammation and anti-inflammatory therapies for cystic fibrosis","volume":"28","author":"Chmiel JF","year":"2007","journal-title":"Clin Chest Med"},{"issue":"2","key":"ref168","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2006.06.003","article-title":"Use of high-dose ibuprofen in a pediatric cystic fibrosis center","volume":"6","author":"Fennell PB","year":"2007","journal-title":"J Cyst Fibros"},{"key":"ref169","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1741-7015-10-88","article-title":"State of progress in treating cystic fibrosis respiratory disease","volume":"10","author":"Flume PA","year":"2012","journal-title":"BMC Med"},{"issue":"13","key":"ref170","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJM199503303321303","article-title":"Effect of high-dose ibuprofen in patients with cystic fibrosis","volume":"332","author":"Konstan MW","year":"1995","journal-title":"N Engl J Med"},{"issue":"11","key":"ref171","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1164\/rccm.200702-181OC","article-title":"Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis","volume":"176","author":"Konstan MW","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"ref172","first-page":"CD001505","article-title":"Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis","author":"Lands LC","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"ref173","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jcf.2015.03.007","article-title":"Use of ibuprofen to assess inflammatory biomarkers in induced sputum Implications for clinical trials in cystic fibrosis","volume":"14","author":"Chmiel JF","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"3","key":"ref174","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jpeds.2007.04.009","article-title":"High-dose ibuprofen in cystic fibrosis Canadian safety and effectiveness trial","volume":"151","author":"Lands LC","year":"2007","journal-title":"J Pediatr"},{"issue":"10","key":"ref175","first-page":"CD001915","article-title":"Inhaled corticosteroids for cystic fibrosis","author":"Balfour-Lynn IM","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"ref176","first-page":"CD000407","article-title":"Oral steroids for long-term use in cystic fibrosis","author":"Cheng K","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"ref177","first-page":"CD003428","article-title":"WITHDRAWN Inhaled bronchodilators for cystic fibrosis","volume":"2","author":"Halfhide C","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"ref178","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jcf.2015.03.004","article-title":"Tiotropium Respimat in cystic fibrosis Phase 3 and Pooled phase 2\/3 randomized trials","volume":"14","author":"Ratjen F","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"4","key":"ref179","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith DE","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"ref180","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2015-207360","article-title":"US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis","volume":"71","author":"Floto RA","year":"2016","journal-title":"Thorax"},{"issue":"4","key":"ref181","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jpedsurg.2012.02.019","article-title":"A review of pathophysiology and management of fetuses and neonates with meconium ileus for the pediatric surgeon","volume":"47","author":"Carlyle BE","year":"2012","journal-title":"J Pediatr Surg"},{"issue":"2","key":"ref182","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jpeds.2012.01.052","article-title":"Prevalence of hyponatremia at diagnosis and factors associated with the longitudinal variation in serum sodium levels in infants with cystic fibrosis","volume":"161","author":"Guimar\u00e3es EV","year":"2012","journal-title":"J Pediatr"},{"issue":"6","key":"ref183","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jcf.2009.08.006","article-title":"Evaluation of salt supplementation in CF infants","volume":"8","author":"Coates AJ","year":"2009","journal-title":"J Cyst Fibros"},{"issue":"6 Suppl","key":"ref184","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jpeds.2009.09.001","article-title":"Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis","volume":"155","author":"Borowitz D","year":"2009","journal-title":"J Pediatr"},{"issue":"4","key":"ref185","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jpeds.2012.10.008","article-title":"Evolution of pancreatic function during the first year in infants with cystic fibrosis","volume":"162","author":"O'Sullivan BP","year":"2013","journal-title":"J Pediatr"},{"issue":"8","key":"ref186","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1111\/j.1572-0241.2000.02244.x","article-title":"A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency","volume":"95","author":"Stern RC","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"ref187","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S1569-1993(11)60005-2","article-title":"Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients","volume":"10","author":"Colombo C","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"10","key":"ref188","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/ans.12397","article-title":"Distal intestinal obstruction syndrome in cystic fibrosis presentation, outcome and management in a tertiary hospital (2007-2012)","volume":"84","author":"Subhi R","year":"2014","journal-title":"ANZ J Surg"},{"key":"ref189","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","article-title":"Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease","volume":"10","author":"Debray D","year":"2011","journal-title":"J Cyst Fibros"},{"key":"ref190","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005176-199900001-00001","article-title":"Recommendations for management of liver and biliary tract disease in cystic fibrosis Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group","volume":"28","author":"Sokol RJ","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"ref191","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/oxfordjournals.bmb.a072583","article-title":"Liver and biliary problems in cystic fibrosis","volume":"48","author":"Williams SG","year":"1992","journal-title":"Br Med Bull"},{"issue":"6","key":"ref192","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/MCP.0b013e3282f10a16","article-title":"Liver disease in cystic fibrosis","volume":"13","author":"Colombo C","year":"2007","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"ref193","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00005176-200209000-00004","article-title":"Consensus report on nutrition for pediatric patients with cystic fibrosis","volume":"35","author":"Borowitz D","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"ref194","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jada.2008.02.020","article-title":"Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency results of a systematic review","volume":"108","author":"Stallings VA","year":"2008","journal-title":"J Am Diet Assoc"},{"issue":"9","key":"ref195","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2471\/BLT.07.043497","article-title":"Development of a WHO growth reference for school-aged children and adolescents","volume":"85","author":"de Onis M","year":"2007","journal-title":"Bull World Health Organ"},{"key":"ref196","series-title":"WHO child growth standards and the identification of severe acute malnutrition in infants and children: a joint statement by the World Health Organization and the United Nations Children's Fund","year":"2009"},{"issue":"6","key":"ref197","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jcf.2015.07.011","article-title":"Estimating body composition from skinfold thicknesses and bioelectrical impedance analysis in cystic fibrosis patients","volume":"14","author":"Alicandro G","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"5","key":"ref198","first-page":"CD001914","article-title":"Oral protein calorie supplementation for children with chronic disease","author":"Francis DK","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"ref199","first-page":"CD000406","article-title":"Oral calorie supplements for cystic fibrosis","author":"Smyth RL","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"ref200","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/MCO.0000000000000100","article-title":"Protein is an important but undervalued macronutrient in the nutritional care of patients with cystic fibrosis","volume":"17","author":"Engelen MP","year":"2014","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"3","key":"ref201","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/ajcn\/84.3.523","article-title":"Energy balance and the accuracy of reported energy intake in preadolescent children with cystic fibrosis","volume":"84","author":"Trabulsi J","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"ref202","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1569-1993(02)00032-2","article-title":"Nutrition in patients with cystic fibrosis a European Consensus","volume":"1","author":"Sinaasappel M","year":"2002","journal-title":"J Cyst Fibros"},{"issue":"6","key":"ref203","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/MCP.0b013e3283136787","article-title":"Update on fat-soluble vitamins in cystic fibrosis","volume":"14","author":"Maqbool A","year":"2008","journal-title":"Curr Opin Pulm Med"},{"issue":"12","key":"ref204","first-page":"CD009422","article-title":"Vitamin E supplementation in people with cystic fibrosis","author":"Okebukola PO","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"ref205","first-page":"CD006751","article-title":"Vitamin A supplementation for cystic fibrosis","author":"Bonifant CM","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"ref206","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/ajcn\/85.5.1307","article-title":"Cholecalciferol significantly increases 25-hydroxyvitamin D concentrations in adults with cystic fibrosis","volume":"85","author":"Stephenson A","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"ref207","first-page":"CD008482","article-title":"Vitamin K supplementation for cystic fibrosis","volume":"1","author":"Jagannath VA","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"ref208","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1164\/rccm.201403-0576OC","article-title":"Diabetes-related mortality in adults with cystic fibrosis Role of genotype and sex","volume":"191","author":"Lewis C","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"ref209","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran A","year":"2010","journal-title":"Diabetes Care"},{"key":"ref210","first-page":"65","article-title":"ISPAD Clinical Practice Consensus Guidelines 2014 Management of cystic fibrosis-related diabetes in children and adolescents","volume":"15","author":"Moran A","year":"2014","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"ref211","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/resp.12227","article-title":"Australian standards of care for cystic fibrosis-related diabetes","volume":"19","author":"Middleton PG","year":"2014","journal-title":"Respirology"},{"issue":"7006","key":"ref212","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/bmj.311.7006.655","article-title":"Glucose tolerance in patients with cystic fibrosis five year prospective study","volume":"311","author":"Lanng S","year":"1995","journal-title":"BMJ"},{"issue":"3","key":"ref213","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.prrv.2009.05.001","article-title":"Update on cystic fibrosis-related bone disease a special focus on children","volume":"10","author":"Sermet-Gaudelus I","year":"2009","journal-title":"Paediatr Respir Rev"},{"issue":"4","key":"ref214","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/pedi.12014","article-title":"Exogenous insulin requirements do not differ between youth and adults with cystic fibrosis related diabetes","volume":"14","author":"Sunni M","year":"2013","journal-title":"Pediatr Diabetes"},{"issue":"3","key":"ref215","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1210\/jc.2004-1629","article-title":"Guide to bone health and disease in cystic fibrosis","volume":"90","author":"Aris RM","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"ref216","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jcf.2004.08.002","article-title":"Randomised double blind placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adult patients with cystic fibrosis","volume":"3","author":"Haworth CS","year":"2004","journal-title":"J Cyst Fibros"},{"issue":"3","key":"ref217","first-page":"CD002010","article-title":"Bisphosphonates for osteoporosis in people with cystic fibrosis","author":"Conwell LS","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"21","key":"ref218","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.12968\/bjon.2012.21.Sup21.S28","article-title":"The strategic role of the nurse in the selection of IV devices","volume":"21","author":"Santolim TQ","year":"2012","journal-title":"Br J Nurs"},{"issue":"5","key":"ref219","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2500\/ajra.2013.27.3919","article-title":"Cystic fibrosis chronic rhinosinusitis a comprehensive review","volume":"27","author":"Chaaban MR","year":"2013","journal-title":"Am J Rhinol Allergy"},{"issue":"3","key":"ref220","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.prrv.2008.04.003","article-title":"Nasal and sinus disease in cystic fibrosis","volume":"9","author":"Robertson JM","year":"2008","journal-title":"Paediatr Respir Rev"},{"issue":"12","key":"ref221","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archotol.131.12.1097","article-title":"Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease","volume":"131","author":"Cimmino M","year":"2005","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"4","key":"ref222","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jcf.2014.02.005","article-title":"Sinonasal inhalation of dornase alfa administered by vibrating aerosol to cystic fibrosis patients a double-blind placebo-controlled cross-over trial","volume":"13","author":"Mainz JG","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"2","key":"ref223","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.anl.2010.09.001","article-title":"Sinonasal inhalation of dornase alfa in CF A double-blind placebo-controlled cross-over pilot trial","volume":"38","author":"Mainz JG","year":"2011","journal-title":"Auris Nasus Larynx"},{"issue":"2","key":"ref224","first-page":"63","article-title":"A prospective treatment trial of nasal polyps in adults with cystic fibrosis","volume":"38","author":"Hadfield PJ","year":"2000","journal-title":"Rhinology"},{"issue":"6","key":"ref225","first-page":"CD008253","article-title":"Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis","author":"Beer H","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"ref226","first-page":"641","article-title":"Lung transplantation an overview of candidacy and outcomes","volume":"14","author":"Rampolla R","year":"2014","journal-title":"Ochsner J"},{"key":"ref227","doi-asserted-by":"crossref","first-page":"621342","DOI":"10.1155\/2014\/621342","article-title":"Practical guidelines lung transplantation in patients with cystic fibrosis","volume":"2014","author":"Hirche TO","year":"2014","journal-title":"Pulm Med"},{"issue":"1","key":"ref228","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2014.06.014","article-title":"A consensus document for the selection of lung transplant candidates 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation","volume":"34","author":"Weill D","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"ref229","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S1569-1993(11)60007-6","article-title":"End of life care for patients with cystic fibrosis","volume":"10","author":"Sands D","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"5","key":"ref230","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jcf.2008.03.001","article-title":"Contraceptive practices in women with cystic fibrosis","volume":"7","author":"Plant BJ","year":"2008","journal-title":"J Cyst Fibros"},{"issue":"3","key":"ref231","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-Ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR","volume":"373","author":"Wainwright CE","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"ref232","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1183\/09031936.00018712","article-title":"Oral contraceptives do not appear to affect cystic fibrosis disease severity","volume":"41","author":"Kernan NG","year":"2013","journal-title":"Eur Respir J"},{"key":"ref233","series-title":"Department for Health and Ageing. SA Maternal & Neonatal Clinical Network. Clinical practice guideline on cystic fibrosis in pregnancy","year":"2015","edition":"3"},{"key":"ref234","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jcf.2007.10.001","article-title":"Guidelines for the management of pregnancy in women with cystic fibrosis","volume":"7","author":"Edenborough FP","year":"2008","journal-title":"J Cyst Fibros"},{"issue":"1","key":"ref235","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1576\/toag.11.1.19.27464","article-title":"Cystic fibrosis and pregnancy","volume":"11","author":"Goddard J","year":"2009","journal-title":"TOG"},{"issue":"3","key":"ref236","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1378\/chest.129.3.706","article-title":"Impact of pregnancy on women with cystic fibrosis","volume":"129","author":"McMullen AH","year":"2006","journal-title":"Chest"},{"issue":"10","key":"ref237","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1113\/jphysiol.2008.164970","article-title":"The cystic fibrosis transmembrane conductance regulator in reproductive health and disease","volume":"587","author":"Chan HC","year":"2009","journal-title":"J Physiol"},{"issue":"1","key":"ref238","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcf.2004.12.002","article-title":"Standards of care for patients with cystic fibrosis a European consensus","volume":"4","author":"Kerem E","year":"2005","journal-title":"J Cyst Fibros"},{"issue":"3","key":"ref239","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ppul.21103","article-title":"Motivational interviewing for adherence problems in cystic fibrosis","volume":"45","author":"Duff AJ","year":"2010","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"ref240","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1378\/chest.13-1926","article-title":"Pulmonary medication adherence and health-care use in cystic fibrosis","volume":"146","author":"Quittner AL","year":"2014","journal-title":"Chest"},{"issue":"2","key":"ref241","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcf.2008.09.007","article-title":"High treatment burden in adults with cystic fibrosis challenges to disease self-management","volume":"8","author":"Sawicki GS","year":"2009","journal-title":"J Cyst Fibros"},{"issue":"10","key":"ref242","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1440-1754.2006.00943.x","article-title":"Treatment burden and health-related quality of life of children with diabetes, cystic fibrosis and asthma","volume":"42","author":"Ziaian T","year":"2006","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"ref243","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/thoraxjnl-2015-207488","article-title":"International Committee on Mental Health in Cystic Fibrosis Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety","volume":"71","author":"Quittner AL","year":"2016","journal-title":"Thorax"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/jbpneu\/v43n3\/1806-3713-jbpneu-43-03-00219.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T12:02:00Z","timestamp":1623931320000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1806-37132017000300219&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":243,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,6]]}},"alternative-id":["S1806-37132017000300219"],"URL":"https:\/\/doi.org\/10.1590\/s1806-37562017000000065","relation":{},"ISSN":["1806-3756"],"issn-type":[{"value":"1806-3756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}